FDA approves new class of medicines to treat pediatric type 2 diabetes
The U.S. Food and Drug Administration (FDA) this week granted approvals of Jardiance (empagliflozin) and Synjardy (empagliflozin and metformin hydrochloride) as additions to diet and exercise to improve blood sugar control in children 10 years and older with type 2 diabetes. Read More
Bio-Techne to acquire Swiss spatial biology firm Lunaphore
Bio-Techne announced Thursday that it has reached an agreement to acquire Tolochenaz, Switzerland-based Lunaphore, a developer of fully automated spatial biology products. Read More
Eli Lilly acquiring immune therapy developer Dice Therapeutics for $2.4B
Eli Lilly said this week it has inked an agreement to acquire Dice Therapeutics, a biopharma firm developing novel oral therapeutic candidates, for $2.4 billion in cash. Read More
Screening newborns for severe combined immunodeficiency saves lives
Widespread screening and early treatment of newborn babies with severe combined immunodeficiency (SCID) boosted their five-year survival rate from 73% to 87% in a study. Read More
Discovery of role protein plays in HIV replication points to ‘shock and kill’ treatment strategy
The identification of a protein that helps HIV to evade the immune system has led scientists to propose a two-step “shock and kill” approach to eliminating the virus. Read More
Scanning ion conductance spectroscopy in study enables precise DNA identification
Researchers at the Ecole Polytechnique Fédérale de Lausanne (EPFL) have developed a new nanopore approach for manipulating individual molecules such as DNA that allows unprecedented control and precision. Read More
New medication offers hope for metastatic colorectal cancer patients
An international clinical trial showed that selective targeted colorectal cancer therapy with the oral medication fruquintinib resulted in statistically significant improvements in both overall and progression-free survival rates. Read More
Uncovering the cellular processes that trigger chronic inflammation
Cedars-Sinai Medical Center investigators have identified several steps in the cellular process responsible for triggering one of the body’s important inflammatory responses. Read More
Alzheimer’s and encephalopathy linked to eye biomarkers
A Boston Medical Center study discovered significant connections between biomarkers present in the vitreous humor of the eye and confirmed cases of Alzheimer's disease and chronic traumatic encephalopathy. Read More
Generative AI correctly diagnoses 39% of complex, challenging medical cases
The generative artificial intelligence (AI) model GPT-4 correctly diagnosed 39% of challenging medical cases in a study published in JAMA. Read More
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Connect
